{
    "id": "60290a131cb411341a000109",
    "question": "Is there an association of alterations in ADCY7 and ulcerative colitis?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to analyze the relationship between alterations in ADCY7 and ulcerative colitis. The provided documents do not explicitly mention ADCY7 in relation to ulcerative colitis. However, we can try to find a connection by examining the genetic factors associated with inflammatory bowel disease (IBD) and ulcerative colitis. According to Document [2], several genes are associated with IBD, including NOD2, ATG16L1, and IRGM. These genes are involved in innate immune function and are thought to contribute to the pathogenesis of IBD. Document [12] also mentions that defects in regulatory T cells, especially the IL-10-producing subset, are believed to underlie the inflammation in Crohn disease. However, there is no direct mention of ADCY7 in the provided documents. Therefore, we can conclude that there is no clear association between ADCY7 and ulcerative colitis based on the provided information.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "Pathology_Robbins_3770",
            "title": "Pathology_Robbins",
            "content": "Although precise causes are not yet defined, most investigators believe that IBD results from the combined effects of alterations in host interactions with intestinal microbiota, intestinal epithelial dysfunction, aberrant mucosal immune responses, and altered composition of the gut microbiome. This view is supported by epidemiologic, genetic, and clinical studies as well as data from laboratory models of IBD ( Fig. 15.27 Genetics. Risk for disease is increased when there is an affected family member, and in Crohn disease, the concordance rate for monozygotic twins is approximately 50%. By contrast, concordance of monozygotic twins for ulcerative colitis is only 16%, suggesting that genetic factors are less dominant in this form of IBD."
        },
        {
            "id": "Surgery_Schwartz_8445",
            "title": "Surgery_Schwartz",
            "content": "dys-regulation. An autoimmune mechanism has also been postulated. Although there is no clear evidence linking an immunologic disorder to inflammatory bowel disease, the similarity of many of the extraintestinal manifestations to rheumatologic disorders has made this theory attractive. In summary, IBD is primarily characterized by intestinal inflammation, and medical therapy is focused on reducing or preventing that inflammation.45-49Pathology and Differential Diagnosis. Although ulcer-ative colitis and Crohn\u2019s colitis share many pathologic and clinical similarities, these conditions can be differentiated in 85% of patients. Ulcerative colitis is a mucosal process in which the colonic mucosa and submucosa are infiltrated with inflammatory cells. The mucosa may be atrophic, and crypt abscesses are common. Endoscopically, the mucosa is fre-quently friable and may possess multiple inflammatory pseu-dopolyps. In long-standing ulcerative colitis, the colon may be foreshortened and the"
        },
        {
            "id": "InternalMed_Harrison_22851",
            "title": "InternalMed_Harrison",
            "content": "The genetic factors defined to date that are recognized to mediate risk for IBD have highlighted the importance of several common mechanisms of disease (Table 351-3). These include the following: those genes that are associated with fundamental cell biologic Abbreviations: CD, Crohn\u2019s disease; IBD, inflammatory bowel disease; IL, interleukin; UC, ulcerative colitis."
        },
        {
            "id": "Pathology_Robbins_3766",
            "title": "Pathology_Robbins",
            "content": "Inflammatory bowel disease (IBD) is a chronic condition resulting from complex interactions between intestinal microbiota and host immunity in genetically predisposed individuals resulting an inappropriate mucosal immune activation. IBD encompasses two entities, Crohn disease and ulcerative colitis. The distinction between ulcerative colitis and Crohn disease is based, in large part, on the distribution of affected sites and the morphologic expression of disease at those sites ( Fig. 15.26 Table 15.5 ). Ulcerative colitis is limited to the colon and rectum and extends only into the mucosa and submucosa. By contrast, Crohn disease, also referred to as regional enteritis (because of frequent ileal involvement), may involve any area of the gastrointestinal tract and is frequently transmural."
        },
        {
            "id": "InternalMed_Harrison_22867",
            "title": "InternalMed_Harrison",
            "content": "ULCERATIVE COLITIS: MACROSCOPIC FEATURES"
        },
        {
            "id": "Pathology_Robbins_3775",
            "title": "Pathology_Robbins",
            "content": "Defects in regulatory T cells, especially the IL-10producing subset, are believed to underlie the inflammation especially in Crohn disease. Mutations in the IL-10 receptor are associated with severe, early-onset colitis. Thus, some combination of excessive immune activation by intestinal microbes and defective immune regulation likely is responsible for the chronic inflammation in both forms of IBD."
        },
        {
            "id": "Surgery_Schwartz_8449",
            "title": "Surgery_Schwartz",
            "content": "Physical findings are also related to the site and severity of disease.In 15% of patients with colitis from inflammatory bowel disease, differentiation of ulcerative colitis from Crohn\u2019s colitis is impossible either grossly or microscopically (indeterminate colitis).50 These patients typically present with symptoms similar to ulcerative colitis. Endoscopic and pathologic findings usually include features common to both diseases. Increasingly, sero-logic markers have been employed to differentiate ulcerative colitis from Crohn\u2019s disease. The anti-Saccharomyces cerevi-siae antibody (ASCA) and perinuclear anticytoplasmic antibody (pANCA) may be useful in differentiating these two processes but require prospective study.50 Further differential diagnoses include infectious colitides, especially cytomegalovirus (CMV), Campylobacter jejuni, Entamoeba histolytica, toxigenic E Coli, C difficile, Neisseria gonorrhoeae, Salmonella, and Shigella species.Brunicardi_Ch29_p1259-p1330.indd"
        },
        {
            "id": "InternalMed_Harrison_22872",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 351-4 Medium-power view of colonic mucosa in ulcerative colitis showing diffuse mixed inflammation, basal lymphoplasmacytosis, crypt atrophy and irregularity, and superficial erosion. These features are typical of chronic active ulcerative colitis. (Courtesy of Dr. R. Odze, Division of Gastrointestinal Pathology, Department of Pathology, Brigham and Women\u2019s Hospital, Boston, Massachusetts; with permission.) The neutrophils invade the epithelium, usually in the crypts, giving rise to cryptitis and, ultimately, to crypt abscesses (Fig. 351-4). Ileal changes in patients with backwash ileitis include villous atrophy and crypt regeneration with increased inflammation, increased neutrophil and mononuclear inflammation in the lamina propria, and patchy cryptitis and crypt abscesses. CROHN\u2019S DISEASE: MACROSCOPIC FEATURES"
        },
        {
            "id": "Surgery_Schwartz_8441",
            "title": "Surgery_Schwartz",
            "content": "polygenic, explaining why IBD frequently affects multiple family mem-bers across more than one generation, while also explaining the large number of genes implicated in the development of IBD. Most of the data on the genetics of IBD focus on Crohn\u2019s disease. Although ulcerative colitis has an association with at least 20 genetic loci based on genome-wide association studies (GWAS), this form of IBD has a weaker genetic link than does Crohn\u2019s disease. Approximately 10% to 30% of IBD patients will have at least one other family member also affected by IBD.39,40 Additionally, there is 50% disease concordance among monozygotic twins and a 10% disease concordance among dizy-gotic twins.41Many of the genetic variants most consistently associated with IBD involve loci involved in innate immune function. These include NOD2 (nucleotide-binding oligomerization domain-containing protein 2), which is located on chromosome 16 and which is responsible for coordinating the function of several genes"
        },
        {
            "id": "Pathology_Robbins_3845",
            "title": "Pathology_Robbins",
            "content": "Mosadeghi S, Bhuket T, Stollman N: Diverticular disease: evolving concepts in classification, presentation, and management, Curr Opin Gastroenterol 31:50\u201355, 2015. [A review of diverticulitis and approaches to its treatment.] Jostins L, Ripke S, Weersma RK, et al: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease, Nature 491:119\u2013124, 2012. [A comprehensive review of polymorphisms linked to inflammatory bowel disease and their relationship to immune defense.] Rogler G: Chronic ulcerative colitis and colorectal cancer, Cancer Lett 345:235\u2013241, 2014. [A review of colitis-associated cancer.] Brenner H, Kloor M, Pox CP: Colorectal cancer, Lancet 383:1490\u20131502, 2014. [A clinically oriented review of colorectal cancer.] Corley DA, Levin TR: Doubeni CA: Adenoma detection rate and risk of colorectal cancer and death, N Engl J Med 370:2541, 2014. [A study of adenoma detection and relationship to cancer risk.]"
        },
        {
            "id": "Obstentrics_Williams_7455",
            "title": "Obstentrics_Williams",
            "content": "Symptoms depend on which bowel segment(s) is involved. Thus, complaints may include lower-right-sided cramping abdominal pain, diarrhea, weight loss, lowgrade fever, and obstructive symptoms. The disease is chronic with exacerbations and remissions, and importantly, it cannot be cured medically or surgically. Approximately a third of patients require surgery within the first year ater diagnosis, and thereater, 5 percent per year. Reactive arthritis is common, and the gastrointestinal cancer risk, although not as great as. with ulcerative colitis, is increased substantially. FIGURE 54-2 Causes of colitis. A.Chronic ulcerative colitis with diffuse ulcerations and exudates. B. Crohn colitis with deep ulcers. (Reproduced with permission from Song LM Topazian M: Gastointestinal endoscopy. Kasper DL, Fauci AS, Hauser SL, et al (eds): Harrison's Principles of Internal Medicine, 19th ed. New York: McGraw-Hili Education; 201o5.)"
        },
        {
            "id": "Pathology_Robbins_3772",
            "title": "Pathology_Robbins",
            "content": "The search for IBD-associated genes using genome-wide association studies (GWAS) that assess single-nucleotide polymorphisms (SNPs) as well as high throughput sequencing and other approaches have yielded a rich harvest of over 200 genes associated with IBD. Among these, NOD2, discussed above, and two autophagy\u2013related genes are of particular interest. They are ATG16L1 (autophagy-related 16\u2013like-1) and IRGM (immunity-related GTPase M) Barrier defects lead to influxBacteria genes. Both are part of the autophagosome pathway and, like NOD-2, are involved in host cell responses to intracellular bacteria, supporting the hypothesis that inadequate defense against luminal bacteria may be important in the pathogenesis of IBD. None of these genes is associated with ulcerative colitis."
        },
        {
            "id": "Surgery_Schwartz_8161",
            "title": "Surgery_Schwartz",
            "content": "correlates well with the presence of underlying acute and chronic inflammation.Features that allow for differentiation between Crohn\u2019s dis-ease of the colon and ulcerative colitis include the layers of the bowel wall affected (inflammation in ulcerative colitis is limited to the mucosa and submucosa but may involve the full-thickness of the bowel wall in Crohn\u2019s disease) and the longitudinal extent of inflammation (inflammation is continuous and characteristi-cally affects the rectum in ulcerative colitis but may be discon-tinuous and spare the rectum in Crohn\u2019s disease). In the absence of full expression of features of advanced disease, Crohn\u2019s colitis can sometimes be difficult to distinguish from ulcerative colitis. It is also important to remember that although ulcerative colitis is a disease of the colon, it can be associated with inflammatory changes in the distal ileum (backwash ileitis).Clinical PresentationThe most common symptoms of Crohn\u2019s disease are abdominal pain,"
        },
        {
            "id": "InternalMed_Harrison_22871",
            "title": "InternalMed_Harrison",
            "content": "ULCERATIVE COLITIS: MICROSCOPIC FEATURES Histologic findings correlate well with the endoscopic appearance and clinical course of UC. The process is limited to the mucosa and superficial submucosa, with deeper layers unaffected except in fulminant disease. In UC, two major histologic features suggest chronicity and help distinguish it from infectious or acute self-limited colitis. First, the crypt architecture of the colon is distorted; crypts may be bifid and reduced in number, often with a gap between the crypt bases and the muscularis mucosae. Second, some patients have basal plasma cells and multiple basal lymphoid aggregates. Mucosal vascular congestion, with edema and focal hemorrhage, and an inflammatory cell infiltrate of neutrophils, lymphocytes, plasma cells, and macrophages may be present."
        },
        {
            "id": "First_Aid_Step2_318",
            "title": "First_Aid_Step2",
            "content": "Comprises Crohn\u2019s disease and ulcerative colitis (see Figure 2.6-6). Most common in Caucasians and Ashkenazi Jews, appearing most frequently during the teens to early 30s or in the 50s. Table 2.6-6 summarizes the features of IBD. T AB LE 2.6-5. Features of Upper and Lower GI Bleeding"
        },
        {
            "id": "Obstentrics_Williams_7452",
            "title": "Obstentrics_Williams",
            "content": "Ulcerative Colitis and erythema nodosum. Another serious problem is that the risk of colon cancer approaches 1 percent per year. With either This is a mucosal disorder with inflammation confined to the ulcerative colitis or Crohn disease, there is also concern for possuperficial luminal layers of the colon. It typically begins at the sible increased risks for venous thromboembolism (Kappelman, rectum and extends proximally for a variable distance. In approx2011; Novacek, 2010)."
        },
        {
            "id": "InternalMed_Harrison_22859",
            "title": "InternalMed_Harrison",
            "content": "Abbreviations: CD, Crohn\u2019s disease; ER, endoplasmic reticulum; GTPase, guanosine triphosphatase; IL, interleukin; PGE2, prostaglandin E2; UC, ulcerative colitis. Source: Adapted from A Kaser et al: Ann Rev Immunol 28:573, 2010; B Khor et al: Nature 474:307, 2011; and L Jostins et al: Nature 491:119, 2012. in the intestinal lumen. In IBD this suppression of inflammation is altered, leading to uncontrolled inflammation. The mechanisms of this regulated immune suppression are incompletely known."
        },
        {
            "id": "Pathology_Robbins_3767",
            "title": "Pathology_Robbins",
            "content": "Both Crohn disease and ulcerative colitis frequently present during adolescence or in young adults, although some studies suggest a second, smaller peak in the incidence of both diseases after the fifth decade. In Western http://ebooksmedicine.net Table 15.5 Features of Crohn Disease and Ulcerative Colitis Feature Crohn Disease Ulcerative Colitis submucosaPseudopolypsModerateMarkedUlcersDeep, knifelikeSuperficial, broad-basedLymphoid reactionMarkedModerateFibrosisMarkedMild to noneSerositisMarkedNoGranulomasYes (\u223c35%)NoFistulas/sinusesYesNo Perianal fistulaYes (in colonic Nodisease)Fat/vitamin YesNomalabsorptionMalignant potentialWith colonic YesinvolvementRecurrence after CommonNosurgeryToxic megacolonNoYesNOTE: Not all features may be present in a single case."
        },
        {
            "id": "Pathology_Robbins_3776",
            "title": "Pathology_Robbins",
            "content": "Epithelial defects. A variety of epithelial defects have been described in Crohn disease, ulcerative colitis, or both. For example, defects in intestinal epithelial tight junction barrier function occur in patients with Crohn disease and a subset of their healthy first-degree relatives. This barrier dysfunction cosegregates with specific disease-associated NOD2 polymorphisms, and experimental models demonstrate that barrier dysfunction can activate innate and adaptive mucosal immunity and sensitize subjects to disease. Interestingly, the Paneth cell granules, which contain anti-microbial peptides that can affect composition of the luminal microbiota, are abnormal in patients with Crohn disease carrying ATG16L1 mutations, thus providing one potential mechanism in which a defective feedback loop between the epithelium and microbiota could contribute to disease pathogenesis."
        },
        {
            "id": "InternalMed_Harrison_22913",
            "title": "InternalMed_Harrison",
            "content": "UC and CD have similar features to many other diseases. In the absence of a key diagnostic test, a combination of features is used (Table 351-5). Once a diagnosis of IBD is made, distinguishing between UC and CD is impossible initially in up to 15% of cases. These are termed indeterminate colitis. Fortunately, in most cases, the true nature of the underlying colitis becomes evident later in the course of the patient\u2019s disease. Approximately 5% (range 1\u201320%) of colon resection specimens are difficult to classify as either UC or CD because they exhibit overlapping histologic features."
        },
        {
            "id": "Pediatrics_Nelson_2785",
            "title": "Pediatrics_Nelson",
            "content": "The peak incidence of IBD in children is in the second decadeof life. IBD includes Crohn\u2019s disease (CD), which can involve any part of the gut, and ulcerative colitis (UC), which affects only the colon. The incidence of IBD is increasing, especiallyin industrialized countries, for reasons that are unclear. IBD is uncommon in tropical and Third World countries. It is more common in Jewish than in other ethnic populations. Geneticfactors play a role in susceptibility, with significantly higher riskif there is a family history of IBD. Having a first-degree relative with IBD increases the risk about 30-fold. Susceptibilityhas been linked to some HLA subtypes, and linkage analysishas identified multiple other susceptibility loci on several chromosomes. Environmental factors (not yet identified) also seemto play a role because there is often nonconcordance amongmonozygotic twins. It is possible that viral infections can initiate the inflammatory process. Dietary triggers are"
        },
        {
            "id": "Obstentrics_Williams_7450",
            "title": "Obstentrics_Williams",
            "content": "Two presumably noninfectious forms of intestinal inlammation are ulcerative colitis and Crohn disease. Diferentiation between these is important because treatment difers. That said, they both share common features, and sometimes are indistinguishable if Crohn disease involves the colon. he salient clinical and laboratory features shown in Table 54-5 permit a reasonably confident diagnostic diferentiation in most cases. he etiopathogenesis is enigmatic in both, but a genetic predisposition is suspected. Inlammation is thought to result from dysregulated mucosal immune function in response to commensal microbiota, with or without an autoimmune component (Friedman, 2015). TABLE 54-5. Some Shared and Diferentiating Characteristics of Inflammatory Bowel Disease Hereditary More than 100 disease-associated genetic loci-a third shared; Jewish predominance; familial in 5-10% of cases; Turner syndrome; immune dysregulation"
        },
        {
            "id": "Surgery_Schwartz_8442",
            "title": "Surgery_Schwartz",
            "content": "These include NOD2 (nucleotide-binding oligomerization domain-containing protein 2), which is located on chromosome 16 and which is responsible for coordinating the function of several genes leading to the production of proinflammatory cytokines in response to gut microbes. This genetic variant is arguably the most strongly associated with IBD, being strongly connected with Crohn\u2019s disease, although it is also associated with severe pouchitis in patients with a history of ulcerative colitis.42,43The ATG16L1 gene is located on chromosome 2, and its product is involved in the immune response to muramyl dipep-tide, a component of both gram-positive and gram-negative bac-teria that is recognized by the immune system. A related gene, IRGM, is located on chromosome 5, and its product is pivotal in the interferon-gamma\u2013mediated clearance of intracellular pathogens. Variants in this gene are associated with a higher incidence of ileocolic resections in Crohn\u2019s disease patients.42-44Patients"
        },
        {
            "id": "InternalMed_Harrison_3139",
            "title": "InternalMed_Harrison",
            "content": "Hepatol. 2:198, 2004.) important objective data that may establish a diagnosis or characterize the type of diarrhea as a triage for focused additional studies (Fig. 55-3B). If stool weight is >200 g/d, additional stool analyses should be performed that might include electrolyte concentration, 1. Are there general features to suggest malabsorption or inflammatory bowel disease (IBD) such as anemia, dermatitis herpetiformis, edema, or clubbing? 2. Are there features to suggest underlying autonomic neuropathy or collagen-vascular disease in the pupils, orthostasis, skin, hands, or joints? 3. Is there an abdominal mass or tenderness? 4. Are there any abnormalities of rectal mucosa, rectal defects, or altered anal sphincter functions? 5. Are there any mucocutaneous manifestations of systemic disease such as dermatitis herpetiformis (celiac disease), erythema nodosum (ulcerative colitis), flushing (carcinoid), or oral ulcers for IBD or celiac disease?"
        },
        {
            "id": "Pathology_Robbins_4002",
            "title": "Pathology_Robbins",
            "content": "Primary sclerosing cholangitis (PSC) is characterized by inflammation and obliterative fibrosis of intrahepatic and extrahepatic bile ducts, leading to dilation of preserved segments. Irregular biliary strictures and dilations cause the characteristic \u201cbeading\u201d of the intrahepatic and extrahepatic biliary tree seen by MRI. Inflammatory bowel disease (Chapter 15), most commonly ulcerative colitis, coexists in approximately 70% of individuals with PSC. Conversely, the prevalence of PSC in individuals with ulcerative colitis is about 4%. Like inflammatory bowel disease, PSC tends to occur in the third through fifth decades of life and has a 2:1 male predominance (see Table 16.5 http://ebooksmedicine.net Fig. 16.28 Imagingstudiesofapatientwithprimarysclerosingcholangitis."
        },
        {
            "id": "Obstentrics_Williams_7451",
            "title": "Obstentrics_Williams",
            "content": "Hereditary More than 100 disease-associated genetic loci-a third shared; Jewish predominance; familial in 5-10% of cases; Turner syndrome; immune dysregulation Other Chronic and intermittent with exacerbations and remissions; extraintestinal manifestations: arthritis, erythema nodosum, uveitis Major symptoms Diarrhea, tenesmus, rectal bleeding, cramping pain; Fibrostenotic-recurrent RLQ colicky pain; fever chronic, intermittent bladder, interenteric Bowel involvement Mucosa and submucosa of large bowel; usually begins Deep layers small and large bowel; at rectum (40% proctitis only); continuous disease commonly transmural; discontinuous involvement; strictures and fistulas RLQ = right lower quadrant; S cerevisiae = Saccharomyces cerevisiae. Data from Friedman, 201n5; Lichtenstein, 2009; Podolsky, 2002. Ulcerative Colitis and erythema nodosum. Another serious problem is that the risk of colon cancer approaches 1 percent per year. With either"
        },
        {
            "id": "Surgery_Schwartz_8439",
            "title": "Surgery_Schwartz",
            "content": "lower in Asia, Africa, and South America, and among the nonwhite population in the United States. Ulcerative coli-tis incidence peaks during the third decade of life and again in the seventh decade of life. The incidence of Crohn\u2019s disease is slightly lower, 1 to 5 people per 100,000. Crohn\u2019s disease also affects Northern European and Caucasian populations dispro-portionately. Crohn\u2019s disease has a similar bimodal incidence, with most cases occurring between ages 15 to 30 years and ages 60 to 70 years.38 In 15% of patients with inflammatory bowel disease, differentiation between ulcerative colitis and Crohn\u2019s colitis is impossible; these patients are classified as having indeterminate colitis.Etiology. Inflammatory bowel disease is a multifactorial con-dition that includes environmental, genetic, and immune causal elements; the variation in disease distributions and severity, as well as the differential responses to medical therapy, reflect a complex pathophysiology that is not"
        },
        {
            "id": "Surgery_Schwartz_8489",
            "title": "Surgery_Schwartz",
            "content": "prove useful. Proinflammatory cytokines such as interleukin-12 and interferon-\u03b3 are potential targets. Inhibition of immune cell migration has also been sug-gested as an approach. However, it is of paramount importance to drain any and all abscesses before initiating immunosuppres-sive therapy such as corticosteroids or anti-TNF-\u03b1 monoclonal antibodies.54-55Indeterminate ColitisApproximately 15% of patients with inflammatory bowel dis-ease manifest clinical and pathologic characteristics of both ulcerative colitis and Crohn\u2019s disease. Endoscopy, barium enema, and biopsy may be unable to differentiate ulcerative colitis from Crohn\u2019s colitis in this setting. The indications for surgery are the same as those for ulcerative colitis: intracta-bility, complications of medical therapy, and risk of or devel-opment of malignancy. In the setting of indeterminate colitis in a patient who prefers a sphincter-sparing operation, a total abdominal colectomy with end ileostomy may be the best initial"
        },
        {
            "id": "Pathology_Robbins_3773",
            "title": "Pathology_Robbins",
            "content": "Mucosal immune responses. Although the mechanisms by which mucosal immunity contributes to the pathogenesis of ulcerative colitis and Crohn disease are still being deciphered, immunosuppressive and immunomodulatory agents remain mainstays of IBD therapy. Polarization of helper T cells to the TH1 type is well recognized in Crohn disease, and some data suggest that TH17 T cells also contribute to disease pathogenesis. Consistent with this, certain polymorphisms of the IL-23 receptor confer protection from Crohn disease and ulcerative colitis (IL-23 is involved in the development and maintenance of TH17 cells). However, agents that block IL-17 or its receptor have provided no benefit, whereas an antibody that inhibits both TH1-and TH17-inducing cytokines is effective, suggesting that the two T cell subsets may have a synergistic role in the disease. Some data suggest that mucosal production of the TH2-derived cytokine IL-13 is increased in ulcerative colitis, and, to a lesser degree,"
        },
        {
            "id": "Immunology_Janeway_3752",
            "title": "Immunology_Janeway",
            "content": "A prevalent variant of chronic inflammatory disease is inflammatory bowel disease (IBD), which includes two main clinical entities\u2014Crohn\u2019s disease (discussed later in this chapter) and ulcerative colitis. We discuss IBD in this chapter because it has many features of an autoimmune disease, even though it is not primarily targeted against self-tissue antigens. Instead, the targets of the dysregulated immune response in IBD are antigens derived from the commensal microbiota resident in the intestines. Strictly speaking, therefore, IBD is an outlier among autoimmune diseases in that the immune response is not directed against \u2018self\u2019 antigens; rather, it is directed against microbial antigens of the resident, or \u2018self,\u2019 microbiota. Nevertheless, features of immune tolerance breakdown are also seen in IBD, and, as with the organ-specific autoimmune diseases, the tissue destruction wrought by the aberrant immune response is primarily localized to a single organ\u2014the intestines."
        },
        {
            "id": "Pathology_Robbins_3774",
            "title": "Pathology_Robbins",
            "content": "two T cell subsets may have a synergistic role in the disease. Some data suggest that mucosal production of the TH2-derived cytokine IL-13 is increased in ulcerative colitis, and, to a lesser degree, Crohn disease."
        },
        {
            "id": "InternalMed_Harrison_5219",
            "title": "InternalMed_Harrison",
            "content": "The microbiota is a key trigger in the development of inflammatory bowel disease (IBD) in mice that harbor mutations in genes associated with IBD risk in humans. Moreover, components of the gut microbiota can modify the activity of the immune system to ameliorate or prevent IBD. Mice containing a mutant ATG16L1 allele linked to Crohn\u2019s disease are particularly susceptible to IBD. Upon infection with mouse norovirus and treatment with dextran sodium sulfate, expression of a hypomorphic ATG16L1 allele leads to defects in small-intestinal Paneth cells and renders mice significantly more susceptible to ileitis than are wild-type control animals. This process is dependent on the gut microbiota and highlights how the intersection of host genetics, infectious agents, and the microbiota can lead to severe immune pathology; i.e., the pathogenic potential of a microbiota may be context-dependent, requiring a confluence of factors. An important observation is that members of the gut microbiota,"
        }
    ],
    "scores": [
        0.037122916635145844,
        0.03486025278054209,
        0.03383988099279073,
        0.026345318532818532,
        0.02600695483219296,
        0.02475096042169213,
        0.024572827962375463,
        0.024187746339737748,
        0.02415098919771817,
        0.023544657097288674,
        0.023518366820989074,
        0.02305552394319892,
        0.022837498035517836,
        0.02276797647687784,
        0.022248649700894844,
        0.022092198581560283,
        0.022069664288896,
        0.021413547237076648,
        0.019324122479462285,
        0.019069686039964083,
        0.01880736650081464,
        0.018783068783068783,
        0.017982522860571643,
        0.017593297791317596,
        0.017465631852424307,
        0.01731634182908546,
        0.01711167911369395,
        0.01694915254237288,
        0.016680339075745145,
        0.016581719334012913,
        0.01654003899683991,
        0.016421024295040044
    ]
}